Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

May 1, 2025

Study Completion Date

June 1, 2025

Conditions
Community-Acquired Pneumonia (CAP)
Interventions
DRUG

Fei Re Qing Granules

Fei Re Qing Granules (Ingredients: Scutellaria baicalensis \[Huang Qin\], Trichosanthes kirilowii \[Gua Lou\], Forsythia suspensa \[Lian Qiao\], Fritillaria thunbergii \[Zhe Bei Mu\], etc.)

OTHER

Routine standard treatments

Routine standard treatments

DRUG

Placebo granules

The placebo granules are prepared using 5% of the active drug, ensuring consistency in appearance, weight, color, and odor with the Fei Re Qing Granules

All Listed Sponsors
collaborator

Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

OTHER

collaborator

The First Affiliated Hospital of Henan university of CM

UNKNOWN

lead

Henan University of Traditional Chinese Medicine

OTHER

NCT06747325 - Clinical Trial of Fei Re Qing Granules in the Treatment of Elderly Community-Acquired Pneumonia | Biotech Hunter | Biotech Hunter